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1. Introduction  
Under pathological conditions such as tissue inflammation, ischemic stroke, traumatic brain 
injury, and epileptic seizure, accumulations of lactic acid due to enhanced anaerobic glucose 
metabolism and the release of proton from ATP hydrolysis result in significant reduction of 
tissue pH, a condition termed acidosis. Acidosis can activate a distinct family of ion 
channels: acid-sensing ion channels (ASICs) (Waldmann et al., 1997b), which are heavily 
expressed in the peripheral sensory and central neurons (Waldmann & Lazdunski, 1998; 
Krishtal, 2003; Wemmie et al., 2006; Lingueglia, 2007; Xiong et al., 2006, 2007, 2008; Sluka et 
al., 2009). ASICs belong to the amiloride-sensitive degenerin/epithelial Na+ channel 
(DEG/ENaC) superfamily (Kellenberger & Schild, 2002). Four genes (ACCN1 - 4) encoding 
at least six ASIC subunits have been cloned. Each subunit has two transmembrane domains 
with a large extracellular loop and short intracellular N- and C-termini (Waldmann et al., 
1997b). Functional ASICs are trimeric complexes of these subunits (Jasti et al., 2007; 
Gonzales et al., 2009) and most of these subunits can form homomeric and/or heteromeric 
channels (Benson et al., 2002; Baron et al., 2002, 2008; Wemmie et al., 2002, 2003; Askwith et 
al., 2004; Chu et al., 2004, 2006; Xiong et al., 2004; Zha et al., 2006; Sherwood et al., 2011). 
ASICs are enriched in brain neurons (Alvarez de la Rosa et al., 2003; Wemmie et al., 2003; 
Xiong et al., 2004; Sherwood et al., 2011), where at least three (ASIC1a, ASIC2a and ASIC2b) 
of the seven subunits can be found. ASIC1a is the dominant subunit in brain and homomeric 
ASIC1a and heteromeric ASIC1a/2b channels are permeable to both Na+ and Ca2+ ions 
(Waldmann et al., 1997b; Yermolaieva et al., 2004; Zha et al., 2006; Sherwood et al., 2011). 
ASICs are inhibited by the diuretic amiloride, a non-specific ASIC blocker (Waldmann et al., 
1997b). The tarantula toxin psalmotoxin 1 (PcTX1) blocks the homomeric ASIC1a (Escoubas 
et al., 2000) and heteromeric ASIC1a/2b (Sherwood et al., 2011) channels. The roles of ASICs 
in a variety of neurologic conditions are still under active investigation. ASIC1a channels 
localize at synapse and contribute to synaptic plasticity, learning/memory, and fear 
conditioning (Wemmie et al., 2002, 2003, 2004). Activation of Ca2+-permeable homomeric 
ASIC1a and heteromeric ASIC1a/2b channels is involved in acidosis-mediated ischemic 
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brain injury (Xiong et al., 2004; Pignataro et al., 2007; Sherwood et al., 2011). Moreover, 
ASIC1a channels play critical roles in neurodegenerative diseases such as multiple sclerosis 
(Friese et al., 2007; Vergo et al., 2011), Parkinson’s (Arias et al., 2008) and Huntington’s 
(Wong et al., 2008) disease and in seizures (Chang et al., 2007; Ziemann et al., 2008) and 
depression (Coryell et al., 2009). Thus, controlling their activation might ameliorate acidosis-
mediated CNS disorders (Xiong et al., 2008). This chapter provides an overview of recent 
advance in electrophysiological properties as well as pharmacological profiles of ASICs, and 
their roles in neurodegenerative disorders.  
2. Electrophysiological and pharmacological properties of ASICs 
2.1 Electrophysiological properties of ASICs 
The electrophysiological properties and pharmacological profiles of ASICs have been 
extensively explored in heterologous expression systems (Chu et al., 2004; Hesselager et al., 
2004) and in neurons from different brain regions, such as cortex (Varming, 1998; Xiong et 
al., 2004; Chu et al., 2004, 2006), hippocampus (Baron et al., 2002; Askwith et al., 2004), 
striatum (Jiang et al., 2009), cerebellum (Allen & Attwell, 2002), retinal ganglion (Lilley et al., 
2004), and spinal cord (Wu et al., 2004; Baron et al., 2008). Fig. 1 shows typical ASIC current 
mediated by homomeric ASIC1a, 1b, 2a, or 3 channels expressed in CHO cells.  
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Fig. 1. Acid-triggered inward currents in CHO cells expressing indicated ASIC subunits 
Homomeric ASIC1a channels have a pH for half-maximal activation (pH50) between 6.2 and 
6.8 (Babini et al., 2002; Benson et al., 2002; Chu et al., 2002; Jiang et al., 2009). Although the 
precise configuration of ASICs in native neurons is not clear, homomeric ASIC1a and 
heteromeric ASIC1a/2 channels are the major components in brain neurons (Wemmie et al., 
2002; Askwith et al., 2004; Xiong et al., 2004; Jiang et al., 2009; Sherwood et al., 2011). For 
example, our recent studies have shown that rapid drops in extracellular pH from 7.4 to 
lower levels (e.g., 6.5, 6.0, 5.0 and 4.0) induced transient inward currents in cultured 
medium spiny neurons (MSNs) of the mouse striatum (Fig. 2A) (Jiang et al., 2009). The dose-
response curve for activation of ASICs revealed a pH50 value of 6.25 (Fig. 2B). This pH50 
value of ASICs in MSNs is comparable to that of homomeric ASIC1a channels (Walmann et 
al., 1997). The ASIC currents in MSNs had a linear I-V relationship with a reversal potential 
close to +60 mV (Fig. 2C, D), indicating that ASICs in MSNs are Na+-selective. 
In contrast to homomeric ASIC1a channels, the following properties distinguish rodent 
ASIC1b from ASIC1a: (1), although the amino acid sequence of approximately 2/3 of the  
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Fig. 2. Electrophysiological properties of ASICs in cultured mouse MSNs. (A) pH-dependent 
activation of ASIC currentsin in MSNs. (B) Dose-response curve for activation of the 
currents by pH drops. The pH50 value is 6.25 and the Hill coeficient is 0.94. (C) The I-V 
relationship of acid-activated currents with different holding levels by decreasing the pH 
from 7.4 to 6.0 in MSNs. (D) The I-V curve. The extrapolated reversal potential is close to 60 
mV, which is close to the sodium equilibrium potential 
ASIC1a and ASIC1b proteins are identical, there are significant differences in the sequence 
for the first one third (about 172 amino acids) of the protein beginning at the N terminal; this 
sequence includes the intracellular N-terminus, the first transmembrane domain, and the 
proximal part of the ectodomain (Chen et al., 1998; Bassler et al., 2001); (2), the expression of 
ASIC1b in the nervous system is limited to peripheral sensory neurons, while ASIC1a is also 
expressed in the CNS; (3), rodent ASIC1b is impermeable to Ca2+ while ASIC1a channels 
have significant Ca2+ permeability; Interestingly, a recent study has shown that human 
ASIC1b channels are permeable to Ca2+ (Hoagland et al., 2010); (4), the threshold for 
activation of ASIC1b current is lower than ASIC1a (~6.5 for ASIC1b and ~7.0 for ASIC1a) 
and it has lower pH50 (5.9); (5), ASIC1b is potentiated by PcTx1(Chen et al., 2006), which is a 
specific inhibitor of ASIC1a. 
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Homomeric ASIC2a channels are relatively insensitive to proton, with a pH50 of 4.4 (Price et 
al., 1996; Waldmann et al., 1996; Lingueglia et al., 1997). However, ASIC2a subunits can 
associate with ASIC1a to form heteromeric channels in brain (Askwith et al., 2004; Chu et al., 
2004, 2006; Xiong et al., 2004; Jiang et al., 2009). Different from homomeric ASIC2a subunits, 
homomeric ASIC2b subunits do not form functional channels by themselves, but can 
associate with other ASIC subunits to form heteromultimeric channels (Lingueglia et al., 
1997; Hesselager et al., 2004; Sherwood et al., 2011). For example, ASIC2b can be associated 
with ASIC1a to form functional channels and contribute to acidosis-induced neuronal injury 
(Sherwood et al., 2011).  
ASIC3, like ASIC1b (Chen et al., 1998), is expressed primarily in peripheral sensory neurons 
(Waldmann et al., 1997a; Babinski et al., 1999; Wu et al., 2004; Lingueglia, 2007; Lin et al., 
2008). In contrast to other subunits of ASICs, homomeric ASIC3 channels can respond to a 
large drop of extracellular pH with a transient inactivating current followed by a sustained 
component (Waldmann et al., 1997a; Sanilas et al., 2009) (Fig. 1). The transient currents are 
highly sensitive to protons, with a pH50 of around 6.5 (Waldmann et al., 1997a; Hesselager et 
al., 2004). Electrophysiological studies have shown that ASIC3 subunits function as 
homomeric or heteromeric channels in sensory neurons (Sutherland et al., 2001; Benson et 
al., 2002; Deval et al., 2004, 2008; Lin et al., 2008; Hattori et al., 2009). They can sense 
extracellular acidification occurring in physiological and/or pathological processes, such as 
cutaneous touch, pain perception, inflammation and ischemia (Benson et al., 1999; Immke & 
McCleskey, 2001; Price et al., 2001; Sutherland et al., 2001; Mamet et al., 2003; Molliver et al., 
2005; Sluka et al., 2007; Ikeuchi et al., 2009). For example, ASIC3 channels expressed in 
cardiac sensory neurons can respond to myocardial ischemia (Benson et al., 1999; Sutherland 
et al., 2001; Yagi et al., 2006). Further, cutaneous sensory neurons from rats display large 
ASIC3-like currents when stimulated by moderate acidosis (Deval et al., 2008). 
Consequently, it is generally accepted that ASIC3 is a sensor of moderate acidosis during 
ischemia and inflammatory pain in sensory neurons (Lingueglia, 2007).  
ASIC4 subunits are expressed in pituitary gland. Similar to ASIC2b, they do not seem to 
form functional homomeric channels (Aropian et al., 2000; Grunder et al., 2000). 
2.2 Pharmacological profiles of ASICs 
2.2.1 Amiloride 
Amiloride, the potassium-sparing diuretic agent, is a commonly used nonspecific blocker 
for ASICs. It inhibits the ASIC current and acid-induced increase in intracellular Ca2+ 
([Ca2+]i) with an IC50 of 10–60 μM (Waldmann et al., 1997b; de Weille et al., 1998; Chen et al., 
1998; Benson et al., 1999; Chu et al., 2002; Wu et al., 2004; Xiong et al., 2004; Yermolaieva et 
al., 2004; Jiang et al., 2009). For example, our recent study has shown that amiloride dose-
dependently inhibited the ASIC currents in MSNs with an IC50 of 13.6 μM (Fig. 3) (Jiang et 
al., 2009). Unlike the currents mediated by other homomeric ASICs, however, the sustained 
current mediated by homomeric ASIC3 channels is insensitive to amiloride (Waldmann et 
al., 1997b; Benson et al., 1999; Yagi et al., 2006). Based on the studies of ENaC, it is believed 
that amiloride inhibits ASICs by a direct blockade of the channel (Schild et al., 1997; Adams 
et al., 1999). The pre-TM II region of the channel is critical for the effect of amiloride. 
Mutation of Gly-430 in this region, for example, dramatically changed the sensitivity of 
ASIC2a current to amiloride (Champigny et al., 1998). Consistent with its inhibition on the 
ASIC current, amiloride has been shown to suppress acid-induced pain in peripheral 
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sensory system (Ugawa et al., 2002; Sluka et al., 2003; Jones et al., 2004; Dube et al., 2005), 
and acidosis-mediated injury of CNS neurons (Xiong et al., 2004; Yermolaieva et al., 2004). 
However, because of its nonspecificity for other ion channels (e.g., ENaC and T-type Ca2+ 
channels) and ion exchange systems (e.g., Na+/H+ and Na+/Ca2+ exchanger), it is less likely 
that amiloride will be used as a future neuroprotective agent in human subjects. It is worth 
mentioning that the normal activity of Na+/Ca2+ exchanger, for example, is critical for 
maintaining the cellular Ca2+ homeostasis and the survival of neurons against delayed 
calcium deregulation caused by glutamate receptor activation (Bano et al., 2005). Inhibition 
of Na+/Ca2+ exchange by amiloride may therefore compromise normal neuronal Ca2+ 
handling, thus potentiating the glutamate toxicity (Bano et al., 2005). 
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Fig. 3. Dose-dependent blockade of ASIC currents in cultured MSNs by amiloride, a non-
specific ASIC blocker. (A) Amiloride dose-dependently inhibits the ASIC currents activated 
by pH 6.0. (B) Dose-inhibition curve of the acid-induced currents by amiloride. The IC50 of 
amiloride is 13.6 μM 
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2.2.2 A-317567 
A-317567, a small molecule structurally unrelated to amiloride, is another nonselective ASIC 
blocker (Dube et al., 2005). It inhibits the ASIC1a, ASIC2a, and ASIC3-like currents with an 
IC50 of 2–30 μM. Unlike amiloride, which has no effect on the slow component of the ASIC3 
current, A-317567 blocks both the fast and the sustained ASIC3 currents. Also different from 
amiloride, A-317567 does not show diuresis or natriuresis activity (Dube et al., 2005), 
suggesting that it is more specific for ASICs than amiloride. Its inhibition of sustained ASIC3 
current suggests that it might be potent in reducing acidosis-mediated chronic pain. Indeed, 
A-317567 has been shown to be effective in suppressing the pain in a rat model of thermal 
hyperalgesia at a dose tenfold lower than amiloride (Dube et al., 2005). 
2.2.3 PcTX1 
Being a peptide toxin isolated from venom of the South American tarantula Psalmopoeus 
cambridgei, PcTX1 is a potent and specific inhibitor for homomeric ASIC1a channels 
(Escoubas et al., 2000). This toxin contains 40 amino acids cross-linked by three disulfide 
bridges. In heterologous expression systems, PcTX1 specifically inhibits the acid-activated 
current mediated by homomeric ASIC1a subunits with an IC50 of 1 nM (Escoubas et al., 
2000). At concentrations that effectively inhibit the ASIC1a current, it has no effect on the 
currents mediated by other configurations of ASICs (Escoubas et al., 2000), or known 
voltage-gated Na+, K+, Ca2+ channels as well as several ligand-gated ion channels (Xiong et 
al., 2004). Unlike amiloride, which directly blocks the ASICs, PcTX1 acts as a gating 
modifier. It shifts the channel from its resting state toward the inactivated state by 
increasing its apparent affinity for protons (Chen et al., 2005). Recently, PcTX1 has also been 
shown to suppress heteromeric ASIC1a/2b channels (Sherwood et al., 2011). 
2.2.4 APETx2 
Being a peptide toxin isolated from sea anemone Anthopleura elegantissima, APETx2 is a 
potent and selective inhibitor for homomeric ASIC3 and ASIC3 containing channels 
(Diochot et al., 2004). The toxin contains 42 amino acids, also cross-linked by three disulfide 
bridges. It reduces transient peak acid-evoked currents mediated by homomeric ASIC3 
channels (Diochot et al., 2004). In contrast to the peak ASIC3 current, the sustained 
component of the ASIC3 current is insensitive to APETx2. In addition to homomeric ASIC3 
channels (IC50 = 63 nM for rat and 175 nM for human), APETx2 inhibits heteromeric 
ASIC3/1a (IC50 = 2 μM), ASIC3/1b (IC50 = 900 nM), and ASIC3/2b (IC50 = 117 nM). 
Homomeric ASIC1a, ASIC1b, ASIC2a, and heteromeric ASIC3/2a channels, on the other 
hand, are not sensitive to APETx2 (Diochot et al., 2004). 
2.2.5 Nonsteroid anti-inflammatory drugs (NSAIDs) 
NSAIDs are the most commonly used anti-inflammatory and analgesic agents. They inhibit 
the synthesis of prostaglandins (PGs), a main tissue inflammatory substance. A recent study 
demonstrated that NSAIDs also inhibit the activity of ASICs at their therapeutic doses for 
analgesic effects (Voilley et al., 2001). Ibuprofen and flurbiprofen, for example, inhibit 
ASIC1a containing channels with an IC50 of 350 μM. Aspirin and salicylate inhibit ASIC3 
containing channels with an IC50 of 260 μM, whereas diclofenac inhibits the same channels 
with an IC50 of 92 μM. In addition to a direct inhibition of the ASIC activity, NSAIDs also 
prevent inflammation-induced increase of ASIC expression in sensory neurons (Voilley et 
al., 2001). 
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2.2.6 Aminoglycosides (AGs) 
AGs (streptomycin, neomycin and gentamicin) are a group of antibiotics that have been 
shown to block Ca2+ channels (Zhou and Zhao, 2002), excitatory amino acid receptors (Pérez 
et al., 1991), and transient-receptor-potential V1 channels (Raisinghani and Premkumar, 
2005). Recently, Garza et al determined the effect of AGs on proton-gated ionic currents in 
DRG neurons of the rat, and in human embryonic kidney (HEK)-293 cells (Garza et al., 
2010). In DRG neurons, streptomycin and neomycin produced a significant, reversible 
reduction in the amplitude of proton-gated currents in a concentration-dependent manner. 
In addition, they slowed desensitization rates of ASIC currents. Gentamicin also showed a 
significant reversible action on the ASIC currents. In HEK-293 cells, streptomycin produced 
a significant reduction in the amplitude of the proton-gated current, whereas neomycin and 
gentamicin had no significant effect. These results indicate that ASICs are molecular targets 
for AGs, which may explain, in part, their effects on excitable cells. Moreover, AGs might 
potentially represent a novel class of molecules with high affinity, specificity, and selectivity 
for different ASIC subunits. 
2.2.7 Diarylamidines 
Diarylamidines have been widely used for the treatment of protozoan diseases such as 
trypanosomiasis and leishmaniasis since 1930s (Baraldi et al., 2004; Mishra et al., 2007). 
Recently, Chen and colleges found that four members of the diarylamidines, 4', 6-
diamidino-2-phenylindole, diminazene, hydroxystilbamidine and pentamidine strongly 
inhibit ASIC currents in hippocampal neurons with IC50 of 2.8, 0.3, 1.5 and 38 µM, 
respectively. The inhibitory concentration is much lower than amiloride. Sub-maximal 
concentrations of diminazene also potently accelerate desensitization of ASIC currents in 
hippocampal neurons. Diminazene blocks ASIC1a, -1b, -2a, and -3 currents expressed in 
CHO cells with a rank order of potency 1b > 3 > 2a > or = 1a. This study indicates that 
diarylamidines represent a novel class of non-amiloride ASIC blockers and suggests that 
diarylamidines as small molecules may be developed as therapeutic agents in the treatment 
of ASIC-involved diseases (Chen et al., 2010). 
3. Activation of ASICs induces membrane depolarization and increases 
intracellular Ca
2+
 in brain neurons 
Since all ASICs are Na+-selective channels which have a reversal potential near Na+ 
equilibrium potential (+60 mV), activation of ASICs at normal resting potentials produces 
exclusively inward currents which result in membrane depolarization and the excitation of 
neurons (Baron et al., 2002; Wu et al., 2004; Jiang et al., 2009). For example, our recent study 
has shown that a minor drop in extracellular pH from 7.4 to 6.8 induces significant 
membrane depolarization, which accompanies trains of action potentials (Fig. 4) (Jiang et al., 
2009). This acid-induced membrane depolarization is significantly attenuated by either 
amiloride or PcTX1 (Fig. 4). Tetrodotoxin, a voltage-gated Na+ channel blocker, has little 
effect on the membrane depolarization but completely diminished the action potentials 
triggered by a drop in pH from 7.4 to 6.8. For homomeric ASIC1a channels, acid activation 
induces Ca2+ entry directly through these channels (Walmann et al., 1997b; Chu et al., 2002; 
Xiong et al., 2004; Yermolaieva et al., 2004). In addition, the ASIC-mediated membrane 
depolarization may facilitate the activation of voltage-gated Ca2+ channels and NMDA 
receptor-gated channels (Wemmie et al., 2002; Zha et al., 2006), further promoting neuronal 
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excitation and [Ca2+]i accumulation. The Ca2+-permeability of ASICs in CNS neurons has 
been characterized using fluorescent Ca2+ imaging and ion-substitution protocols (Xiong et 
al., 2004; Yermolaieva et al., 2004). In mouse cortical, striatal and hippocampal neurons, 
activation of ASICs by decreasing in extracellular pH induces increases in [Ca2+]i. This acid-
induced increase in [Ca2+]i could be recorded in the presence of a cocktail blocking other 
voltage-gated and ligand-gated Ca2+ channels (Xiong et al., 2004; Jiang et al., 2009), 
indicating Ca2+ entry directly through ASICs. The acid-induced increase in [Ca2+]i is 
eliminated by specific and non-specific ASIC1a blockade, or by ASIC1 gene knockout (Xiong 
et al., 2004; Yermolaieva et al., 2004; Jiang et al., 2009). Consistent with the finding of 
fluorescent imaging, acid-activated inward current is activated when extracellular solution 
contains Ca2+ as the only conducting cation (Xiong et al., 2004). Thus, homomeric ASIC1a 
channels constitute an additional and important Ca2+ entry pathway for neurons. 
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Fig. 4. pH drop triggered membrane depolarization and action potentials by activation of 
ASICs in cultured MSNs. Membrane depolarization by a drop in pH from 7.4 to 6.8 
subsequently triggered trains of action potentials. The membrane depolarization was 
inhibited by amiloride (A) and PcTX1 (B) 
4. Physiological implications of ASICs in the CNS 
4.1 ASIC1a channels in synaptic plasticity, learning and memory  
A change in pH at the synaptic cleft following synaptic release may render ASICs the 
opportunity to regulate synaptic transmission. The findings that ASICs are present at 
synaptic sites and can interact with postsynaptic density protein 95 as well as C kinase 1-
interacting proteins (Hruska-Hageman et al., 2002; Wemmie et al., 2002; Zha et al., 2006, 
2009) support this notion. Indeed, studies by Wemmie and coworkers have demonstrated 
that ASIC1a activation is involved in synaptic plasticity, learning and memory (Wemmie et 
al., 2002). They demonstrated that high frequency stimulation produces long-lasting  
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potentiation of excitatory postsynaptic potentials (EPSP) in hippocampal slices from wild-
type mice. However, the potentiation of EPSP decays rapidly to the baseline in slices from 
ASIC1a null mice. Further studies showed that the NMDA receptor antagonist D-2-Amino-
5-phosphonovalerate inhibits EPSP summation in slices from wild-type but not ASIC1a-
knockout mice, suggesting that the loss of ASIC1a impaired NMDA-receptor function. 
ASIC1a disruption does not impair presynaptic vesicle release, as evidenced by normal 
single evoked EPSPs and paired-pulse facilitation. Interestingly, a later study by Cho and 
Askwith demonstrated that the presynaptic release probability is increased in cultured 
hippocampal neurons from the ASIC1 knockout mice (Cho & Askwith, 2008). Although 
localizations of ASICs at neuronal cell body and postsynaptic sites have been clearly 
demonstrated (Wemmie et al., 2002; Zha et al., 2006), it remains to be determined whether 
ASICs are also expressed at presynaptic sites. 
4.2 ASIC1a channels in fear-related behavior  
ASIC1a is enriched in key structures of fear circuit (e.g. amygdala) (Wemmie et al., 2003). 
Thus, ASIC1a may influence fear responses. Indeed, Wemmie and colleagues demonstrated 
that ASIC1-null mice display significant deficits in cue and context fear conditioning 
(Wemmie et al., 2003). The loss of ASIC1a also reduces unconditioned fear in the open field 
test, during acoustic startle, and in response to predator odor (Coryell et al., 2007). 
Overexpressing ASIC1a, on the other hand, increases fear conditioning (Wemmie et al., 
2004), but not unconditioned fear responses (Coryell et al., 2008).  
Further studies by Wemmie’s group suggest that activation of ASIC1a in brain 
chemosensors contributes to CO2 induced fear-related behavior (Ziemann et al., 2009). It has 
long been known that breathing CO2 triggers panic attacks in patients with panic disorder, 
and that these patients show an increased sensitivity to CO2 inhalation (Papp et al., 1993). In 
addition, patients with increasing hypercarbia due to respiratory failure become extremely 
anxious. How can CO2 inhalation contribute to fear behavior and related panic disorders? 
Wemmie and colleagues have provided evidence that ASIC1a channels are involved 
(Ziemann et al., 2009). They showed that inhaled CO2 triggers a drop in brain pH and 
induces fear behavior in mice. Eliminating or inhibiting ASIC1a significantly limits this 
activity. Overexpressing ASIC1a in the amygdala rescues the CO2-induced fear deficit in 
ASIC1a null mice. Buffering brain pH, on the other hand, attenuates fear behavior, whereas 
lowering pH in the amygdale reproduces the effect of CO2. These studies provide a novel 
molecular mechanism underlying CO2-induced intense fear and related anxiety/panic 
disorders and define the amygdala as an important chemosensor that detects 
hypercarbia/acidosis and initiates behavioral responses (Ziemann et al., 2009).  
4.3 ASICs and retinal integrity 
pH variations in the retina are involved in the fine-tuning of visual perception. Expression 
of ASICs in the retina suggests that they might play a role (Lilley et al., 2004). One study by 
Ettaiche suggested that ASIC2 is important for retinal function and likely protects against 
light-induced retinal degeneration. They showed that both photoreceptors and neurons of 
the mouse retina express ASIC2a and ASIC2b. Inactivation of the ASIC2 gene in mice leads 
to an increased rod electroretinogram of a- and b-waves, indicating an enhanced gain of 
visual transduction. ASIC2 knockout mice also show more sensitivity to light-induced 
retinal degeneration. Thus, ASIC2 is likely a negative modulator of rod phototransduction,  
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and that functional ASIC2 channels are beneficial for the maintenance of retinal integrity 
(Ettaiche et al., 2004). However, since homomeric ASIC2a channels have an extremely low-
sensitivity to protons (i.e. pH50 of 4.4), it is not clear whether active channel activity is 
required for this role. 
Further studies by Ettaiche and colleagues also suggested an involvement of ASIC1a in 
retinal physiology (Ettaiche et al., 2006). In situ hybridization and immunohistochemistry 
detected the expression of ASIC1a in the outer and inner nuclear layers (cone 
photoreceptors, horizontal cells, some amacrine and bipolar cells) and in the ganglion cell 
layer. ASIC1a knockdown by antisense oligonucleotides and ASIC1a blockade by relatively 
specific inhibitor PcTX1 decreased the photopic a- and b-waves and oscillatory potentials. 
This finding suggests that ASIC1a is involved in normal retinal activity. Interestingly, a 
recent study by Render and colleagues did not detect any remarkable morphological 
changes in cone photoreceptors in ASIC1a-/- mice, at least at 5 or 22-27 weeks of age 
(Render et al., 2010). Thus, the exact role of this subunit in retinal integrity and/or function 
remains to be determined. 
In addition to ASIC1a and ASIC2, a potential role of ASIC3 in retinal function and survival 
has been reported (Ettaiche et al., 2009). Ettaiche and colleagues demonstrated the presence 
of ASIC3 in the rod inner segment of photoreceptors, in horizontal and some amacrine cells. 
ASIC3 is also detected in retinal ganglion cells (RGCs) but contributes little to ASIC currents 
recorded in cultured RGCs. At 2 - 3 months, knockout mice experienced a moderate 
enhancement of scotopic electroretinogram a-wave amplitude and a concomitant increase of 
b-wave amplitude without alteration of retinal structure. Older (8-month-old) mice had 
large reductions in scotopic a- and b-waves, respectively, and reductions in oscillatory 
potential amplitudes associated with complete disorganization of the retina and 
degenerating rod inner segments. At 8 and 12 months of age, GFAP and TUNEL staining 
revealed an up-regulation of GFAP expression in Müller cells and the presence of apoptotic 
cells in the inner and outer retina (Ettaiche et al., 2009). Thus, ASIC3 also appears to be 
required for the maintenance of retina integrity. 
5. ASICs in neurodegenerative diseases 
5.1 ASIC1 channels and multiple sclerosis 
Multiple sclerosis is a neuroinflammatory disease associated with axonal degeneration. 
Although inflammation and demyelination are the primary features of CNS lesions, axonal 
degeneration correlates best with clinical deficits in individuals with this disease. It has been 
suggested that the inflammatory insult leads to axonal degeneration by causing neuronal 
mitochondrial dysfunction, energy failure and alteration of ion exchange mechanisms 
(Waxman, 2006). Since excessive accumulation of Na+ and Ca2+ ions is associated with 
axonal degeneration (Stys & LoPachin, 1998), Friese et al determined whether ASIC1a 
activation, which is known to cause accumulation of Na+ and Ca2+ ions, contributes to such 
process in inflammatory lesions of the CNS (Friese et al., 2007). They showed that in an 
experimental model of autoimmune encephalomyelitis (EAE), ASIC1 null mice exhibit a 
significantly reduced clinical deficit and axonal degeneration as compared to wild-type 
mice. Further, pH measurements in the spinal cord of EAE mice display tissue acidosis 
sufficient to open ASIC1. The ASIC1 gene disruption also shows protective effect in nerve 
explants in vitro. ASIC blockade by amiloride is equally neuroprotective in nerve explants 
and in EAE. Thus, ASIC1a may be a potential target for axon degeneration associated with 
multiple sclerosis. 
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More recently, Vergo et al., from the same group studied acute and chronic EAE and 
multiple sclerosis spinal cord and optic nerve tissues to examine the distribution of ASIC1 
and its relationship with neuronal and glial damage (Vergo et al., 2011). They found that 
ASIC1 was upregulated in axons and oligodendrocytes within lesions from mice with acute 
EAE and from patients with active multiple sclerosis. The expression of ASIC1 was 
associated with axonal damage as indicated by co-localization with the axonal injury marker 
beta amyloid precursor protein. Moreover, blocking ASIC1 with amiloride protected both 
myelin and neurons from damage in the acute model, and when given either at disease 
onset or, more clinically relevant, at first relapse, ameliorated disability in mice with 
chronic-relapsing EAE. Together these findings suggest that blockade of ASIC1 has the 
potential to provide both neuro- and myelo-protective benefits in multiple sclerosis (Vergo 
et al., 2011).  
5.2 ASICs and Parkinson's disease (PD)  
PD is characterized by motor impairments and a loss of dopaminergic neurons in the 
substantia nigra (SNc) (Dauer & Przedborski, 2003). However, the mechanism of neuronal 
injury is not entirely clear. Previous studies have shown that the vulnerable neurons in this 
region also express ASIC1a (Wemmie et al., 2003; Pidoplichko & Dani, 2006). Given that PD, 
like ischemia, is associated with cerebral lactic acidosis, Arias et al tested the effect of ASIC 
blockade in a mouse model of PD induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 
(MPTP) treatment (Arias et al., 2008). As expected, amiloride was found to protect SNc 
neurons from MPTP-induced degeneration, and to preserve dopaminergic cell bodies in the 
SNc. Administration of PcTX venom resulted in a modest effect, attenuating the deficits in 
striatal DAT binding and dopamine. These findings suggest a potential role for ASICs in the 
pathogenesis of Parkinson's disease. 
5.3 ASICs and Huntington's disease (HD) 
HD is a fatal neurodegenerative disorder. Energy metabolism deficit and acidosis have been 
observed in both in vitro and in vivo models of HD as well as in the brains of HD patients 
(Wong et al., 2008). To examine the potential involvement of ASICs in the pathology of HD, 
Wong et al tested effect of amiloride derivative benzamil both in vitro and in vivo (Wong et 
al., 2008). They showed that benzamil markedly reduced the huntingtin-polyglutamine (htt-
polyQ) aggregation in an inducible cellular system. In addition, the effect of benzamil was 
recapitulated in the R6/2 animal model of HD. Further experimentation showed that 
benzamil alleviated the inhibition of ubiquitin-proteasome system (UPS) activity, resulting 
in enhanced degradation of soluble htt-polyQ specifically in its pathological range. Blocking 
the expression of ASIC1a with siRNA also enhanced UPS activity, resulting in decreased htt-
polyQ aggregation in the striatum of R6/2 mice. Thus, targeting ASIC1a might be an 
alternative approach to combat HD and other polyQ-related disorders. 
5.4 ASIC1a and Alzheimer’s disease (AD) 
Based on ASIC1a channels in synaptic plasticity and learning/memory, a recent preliminary 
study has suggested that a reduced function of ASIC1a channels may contribute to the 
learning and memory deficit associated with AD (Maysami et al., 2009). In this study, 
Maysami et al showed that acid-activated currents in mouse cortical neurons and in CHO 
cells expressing ASIC1a are inhibited by nanomolar concentrations of amyloid beta peptide, 
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a critical player for the pathology of AD. In addition to a reduction of current amplitude, 
amyloid beta peptide also slows down the activation of the channels. Thus, restoring the 
activity of ASIC1a channels could be a new intervention for AD. 
5.5 ASICs in depression-related behavior  
Depression disorders are a highly prevalent condition among adults in general population 
but the molecular pathways underlying depression are poorly understood. Recent studies 
by Coryell and colleagues have linked ASIC function to depression-related behavior 
(Coryell et al., 2009). They demonstrated that genetically disrupting ASIC1a in mice 
produced antidepressant-like effects in the forced swim test, the tail suspension test, and 
following unpredictable mild stress. Pharmacologically inhibiting ASIC1a also had 
antidepressant-like effects. The effects of ASIC1a disruption in the forced swim test were 
independent and additive to those of several commonly used antidepressants. Restoring 
ASIC1a to the amygdale of ASIC1a null mice reversed the forced swim test effects. The 
mechanism underlying the involvement of ASIC1a in depression-related behavior is not 
clear. It is likely that brain-derived neurotrophic factor (BDNF) is involved since both 
ASIC1a disruption and inhibition interfere with the ability of stress to reduce BDNF in the 
hippocampus. Thus, antagonists of ASIC1a channels may have potential for combating 
human depression. 
5.6 ASICs and anxiety disorders 
Anxiety disorders are debilitating neuropsychiatric disorders. Current treatments for 
anxiety disorders include pharmacological agents such as benzodiazepines and selective 
serotonin reuptake inhibitors. These agents, while effective in many patients, can induce a 
variety of side effects. Thus, it is necessary to develop a new generation of effective and 
better-tolerated anxiolytic agents. In this regard, Dwyer et al have shown that ASIC1a 
inhibitors have an effect in preclinical rodent models of autonomic and behavioral 
parameters of anxiety (Dwyer et al., 2009). In the stress-induced hyperthermia model, acute 
administration of ASIC inhibitors PcTX1, A-317567, and amiloride prevented stress-induced 
elevations in core body temperature. In the four-plate test, acute treatment with PcTX1 and 
A-317567 produced dose-dependent increases in the number of punished crossings. Further 
experiment showed that infusion of A-317567 into the amygdala significantly elevated the 
extracellular levels of GABA, but not glutamate, in this brain region. These findings suggest 
that ASIC inhibition has anxiolytic-like effects in some behavioral models and that 
GABAergic mechanisms are involved in the effects. 
A recent study also suggests an involvement of ASIC3 in anxiety-like behavior (Wu et al., 
2010). Although it is widely accepted that ASIC3 is predominately distributed in the 
peripheral nervous system, its expression has been found in rat hypothalamus (Meng et al., 
2009). Study by Wu and colleagues also reported the expression of ASIC3 in the sensory 
mesencephalic trigeminal nucleus of mouse brain (Wu et al., 2010). However, whether 
ASIC3 plays any functional role in the brain was unclear. Wu et al showed that, in anxiety 
behavior tasks, ASIC3 null mice spent more time in the open arms of an elevated plus maze 
than did their wild-type littermates. ASIC3 null mice also displayed less aggressiveness 
toward intruders but more stereotypic repetitive behaviors during resident-intruder testing 
than did wild-type littermates. Therefore, loss of ASIC3 produces behavioral changes in 
anxiety and aggression in mice, which suggests that ASIC3-dependent sensory activities 
might be related to the central process of emotion modulation (Wu et al., 2010). 
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Although the studies from ASIC1a and ASIC3 knockout mice indicated that ASICs 
contribute to neuropsychiatric disorders such as depression and anxiety, whether these 
neurological conditions are associated with significant change in local or global pH in the 
CNS remains to be determined. 
5.7 ASICs in acidosis-mediated ischemic neuronal injury 
During neurological conditions such as brain ischemia, increased anaerobic glycolysis due 
to reduced oxygen supply leads to lactic acid accumulation (Rehncrona, 1985). 
Accumulation of lactic acid, alone with increased H+ release from ATP hydrolysis, causes a 
decrease in pH, resulting in brain acidosis. During brain ischemia, for example, extracellular 
pH falls to 6.5 or lowers (Rehncrona, 1985; Nedergaard et al., 1991).  
Acidosis has long been known to play an important role in ischemic brain injury (Tombaugh 
& Sapolsky, 1993; Siesjo, et al., 1996), and a direct correlation of brain acidosis with infarct 
size has been described (Siesjo, 1988). However, the exact mechanism underlying acidosis-
mediated neuronal injury remained uncertain. Severe acidosis may cause non-selective 
denaturation of proteins and nucleic acids (Kalimo et al., 1981); trigger cell swelling through 
stimulation of Na+/H+ and Cl-/HCO3- exchangers, which leads to cellular edema and 
osmolysis (Kimelberg et al., 1990); hinder postischemic metabolic recovery by inhibiting 
mitochondrial energy metabolism and impairing postischemic blood flow via vascular 
edema (Hillered et al., 1985). The stimulation of pathologic free radical formation by acidosis 
has also been described (Rehncrona et al., 1989). At the neurotransmitter level, profound 
acidosis inhibits astrocytic glutamate uptake, which may contribute to excitatory neuronal 
injury (Swanson et al., 1995). Marked acidosis, with tissue pH<5.5, may influence neuronal 
vulnerability indirectly by damaging glial cells (Giffard et al., 1990). 
The widespread expression of ASIC1a in the brain, its activation by pH drops to the level 
commonly seen during ischemia, and its demonstrated role in intracellular Ca2+ 
accumulation suggested a potential involvement of these channels in the pathology of brain 
injury. Indeed, a number of recent studies have demonstrated an important role for ASIC1a 
activation in acidosis-mediated neuronal injury (Xiong et al., 2004; Yermolaieva et al., 2004; 
Gao et al., 2005; Pignataro nt al., 2007; Sherwood et al., 2009, 2011; Gu et al., 2010; Jetti et al., 
2010; Li et al., 2010; Mari et al., 2010). In cultured mouse and human cortical neurons, for 
example, activation of ASICs by acid incubation induced glutamate receptor-independent 
neuronal injury inhibited by specific ASIC1a blockade, and/or by ASIC1 gene knockout 
(Xiong et al., 2004; Li et al., 2010). In rodent models of brain ischemia, intracerebroventricular 
injection of ASIC1a blocker/inhibitor reduced the infarct volume from transient or 
permanent focal ischemia by up to 60%(Xiong et al., 2004; Pignataro et al., 2007). Similarly, 
ASIC1 gene knockout produced significant neuroprotection in mice (Xiong et al., 2004). The 
protection by ASIC1a blockade had a time window of efficacy of up to 5 hours, and the 
protection persists for at least 7 days (Pignataro nt al., 2007).  
More recently, Sherwood et al., found that ASIC2b subunit can form functional channels 
with ASIC1a in cultured hippocampal neurons, and that the heteromeric ASIC1a/2b 
channels are calcium-permeable (Sherwood et al., 2011). Further, activation of heteromeric 
ASIC1a/2b channels contributes to acidosis-induced neuronal death. These data indicate 
that ASIC2, like ASIC1a, plays a role in acidosis-induced neuronal death and implicate the 
ASIC1a/2b subtype as a novel pharmacological target to prevent neuronal injury after 
stroke (Sherwood et al., 2011). 
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Since activation of NMDA receptors and subsequent Ca2+ toxicity have been known to play 
an important role in ischemic brain injury, the outcome of co-application of both antagonists 
has also been investigated. Compared to ASIC1a or NMDA blockade alone, co-application 
of NMDA and ASIC antagonists produced additional neuroprotection, and the presence of 
ASIC1a blockade prolonged the time window of effectiveness of NMDA blockade 
(Pignataro nt al., 2007). Thus, ASIC1a represents a novel pharmacological target for ischemic 
brain injury.  
In contrast to ASIC1a, a study by Johnson and colleagues suggests that an increased ASIC2a 
expression could provide protection against ischemic injury (Johnson et al., 2001). They 
showed an increased ASIC2a expression in neurons that survived global ischemia. This may 
be explained by the possibility that increased ASIC2a expression favors the formation of 
heteromeric ASIC1a/ASIC2a channels with reduced acid-sensitivity and no Ca2+ 
permeability.  
5.8 ASIC activation and epileptic seizure activity  
A significant drop of brain pH during intense neuronal excitation or seizure activity 
(Urbanics et al., 1978; Somjen et al., 1984; Simon et al., 1985, 1987; Chesler & Chan, 1988; 
Chesler & Kaila, 1992) suggests that ASIC activation might occur and activated ASICs then 
play a role in the generation/maintenance of epileptic seizures. However, the exact role of 
ASIC activation in seizure generation, propagation, and termination seems controversial.  
Babinski and colleagues first reported a change of ASIC1a and ASIC2b expression in the 
hippocampal area following pilocarpine-induced epilepticus (Biagini et al., 2001), 
suggesting that the channels containing ASIC1a and ASIC2b subunits might play a role in 
the pathology of epilepsy.  
Later on, a number of studies showed that amiloride, a commonly used non-selective ASIC 
blocker, has an anticonvulsant property in vivo in pilocarpine and pentylenetetrazole models 
of seizures (Ali et al., 2004, 2006; N’Gouemo, 2008), suggesting that ASIC activation might be 
proconvulsant. However, since amiloride also inhibits a number of other channels and ion 
exchange systems, these findings do not define ASICs as a specific target for amiloride to 
achieve its anti-epileptic action.  
Using a number of in vitro epilepsy models, a preliminary study by Chang et al provided 
additional evidence that ASIC1a activation might be proconvulsant (Chang et al., 2007). In a 
cell culture model of epilepsy, brief withdrawal of the NMDA antagonist kynurenic acid 
induces a dramatic increase in the firing of action potentials, in addition to a sustained 
membrane depolarization. ASIC blockade by amiloride and the selective ASIC1a blocker 
PcTX1 significantly inhibited the increase of neuronal firing and the sustained membrane 
depolarization. In hippocampal slices, high frequency electrical stimulation or removal of 
extracellular Mg2+ triggers spontaneous seizure-like bursting. Bath perfusion of amiloride 
and PcTX1 decreased the amplitude and the frequency of these seizure-like bursting 
activities. Similarly, slices prepared from the brains of ASIC1a knockout mice demonstrated 
a reduced sensitivity to low extracellular Mg2+-induced or stimulation-evoked seizure 
activities (Chang et al., 2007). 
In contrast, studies by Ziemann and colleagues, performed largely in vivo, have suggested 
that activation of ASIC1a channels is involved in the termination of epileptic seizure activity 
(Ziemann et al., 2008). An interesting finding by Ziemann and colleagues was that the level 
of ASIC1a expression is higher in GABAergic interneurons than in excitatory neurons 
(Ziemann et al., 2008). Therefore, acidosis generated during seizures might produce more 
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ASIC activation in inhibitory interneurons and facilitate GABAergic transmission, resulting 
in seizure termination. 
The inconsistent data on the role of ASICs in epileptic seizures may result from the use of 
different epilepsy models. The different ages of animals used may also contribute to the 
inconsistency since expression and function of ASICs in CNS neurons undergo dramatic 
developmental changes (Li et al., 2010). In addition, the finding that hippocampal 
interneurons are highly diverse with dramatically different expression level of ASICs (Weng 
et al., 2010) adds additional complexity to this subject. 
6. Conclusion  
ASICs represent new biological components in peripheral sensory and CNS neurons. 
Increasing evidence indicates the involvement of these channels in both physiological and 
pathological processes of CNS (Grunder & Chen, 2010). Therefore, targeting these channels 
may provide novel and effective therapeutic interventions for a number of CNS diseases. In 
addition to establishing ASIC-specific small molecule antagonists that can easily pass 
through the blood brain barrier, alternative strategies may consider targeting endogenous 
modulators that are known to influence the expression and/or activity of these channels.  
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